BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
March 20, 2013
View Archived Issues
Chinese med-tech firm seeks to win in China, then disrupt U.S. market
SHANGHAI – In China, local med-tech manufacturers have successfully pushed multinationals' products to the side at least in some product lines, due to strong government incentives, their low cost and improved quality.
Read More
To go or not to go: study examines obesity and THA
Read More
Washington roundup: House hearing calls on FDA to finalize mobile guidance
Read More
DiaTech assay helps docs tailor cancer treatment
Read More
Deals roundup: DSM and SpineVision in license, supply agreement for Bionate II
Read More
Financings roundup: HPT prices public offering of 14M shares at $25.55
Read More
Report from Europe: InspireMD wins CE mark for Nitinol carotid EPS
Read More
Agreements/contracts: GSD establishes distribution partnerships for Thunderbolt
Read More
Product Briefs
Read More
People in the News
Read More
Keeping you up to date on recent developments in oncology
Read More
